Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 5;768(2):255-60. doi: 10.1016/s1570-0232(01)00588-8.

Abstract

A simple method is described for the determination of the cyclooxygenase-2 specific inhibitor celecoxib in human serum by HPLC using the demethylated analogue as internal standard. After protein precipitation with acetonitrile, samples were extracted with chloroform. Separation was achieved on a Prontosil C18 AQ column (150x3 mm I.D., 3-microm particle size) at a flow-rate of 0.35 ml/min using water-acetonitrile (40:60, v/v) as the mobile phase. Using fluorescence detection with excitation at 240 nm and emission at 380 nm, the limit of quantification was 12.5 ng/ml for a sample size of 0.5 ml of serum. The assay was linear in the concentration range of 12.5-1500 ng/ml and showed good accuracy and reproducibility. At all concentrations intra- and inter-assay variabilities were below 11% with less than 9% error. The method was applied to the determination of celecoxib for pharmacokinetic studies in man.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Celecoxib
  • Chromatography, High Pressure Liquid / methods*
  • Cyclooxygenase Inhibitors / blood*
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Humans
  • Pyrazoles
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrometry, Fluorescence
  • Sulfonamides / blood*
  • Sulfonamides / pharmacokinetics

Substances

  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib